Detalhe da pesquisa
1.
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis.
Haematologica;
108(3): 833-842, 2023 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36200419
2.
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis.
Blood;
135(4): 293-296, 2020 01 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31714952
3.
Case Report: A rare case of small bowel obstruction secondary to plasma cell myeloma.
Front Oncol;
12: 934566, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35992811
4.
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.
Leukemia;
36(8): 2076-2085, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35610346
5.
Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice.
Leuk Lymphoma;
60(12): 2968-2974, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31169049
6.
Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.
Leuk Lymphoma;
62(13): 3311-3312, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34261423
7.
The advantages of switch to subcutaneous bortezomib in the real life.
Leuk Lymphoma;
59(6): 1505-1507, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28980500